Agoracom Blog Home

Posts Tagged ‘n95’

Maitri Health Technologies $MTEC Chosen for U.K. Trade Mission $DOC.ca $DOCRF $WELL.ca $PRN.ca

Posted by AGORACOM-AB at 2:35 PM on Tuesday, April 20th, 2021
Maitri Health Technologies MTEC
  • British Columbia government selects Maitri as provincial HealthTech leader; Virtual event designed to open doors, facilitate partnerships, expand business

VANCOUVER, BC , April 20, 2021 /CNW/ – Maitri Health Technologies Corp. (” Maitri “) (CSE: MTEC) (FRA: D84), a global platform for healthcare supply security, today announced it has been asked by the British Columbia Ministry of Jobs, Economic Recovery & Innovation to join a government-supported virtual trade mission to the United Kingdom.

The virtual trade mission will showcase an exclusive group of innovative B.C. HealthTech companies which are expanding business and development in the U.K., the world’s fifth largest economy.

“We’re honoured to be selected by B.C. Trade and Invest to represent B.C. HealthTech leadership,” said Andrew Morton , CEO of Maitri. “A government-supported trade mission can help opens doors, make connections and accelerate our existing European efforts to expand awareness and drive sales.”

“The timing is also opportune to help a market in transition. The U.K. is ramping up vaccinations but still fighting the long-term spread of COVID-19. Our digital strategy is to help protect people today with data intelligence and transition into to a fully functioning economy. Our goal is to provide a safe return to workplaces with long-term security that they stay open,” said Morton.

The trade mission, scheduled for April 26-30 , will be delivered in association with GTM Global and Vita Healthcare Solutions. B.C. Trade and Invest, which chose just 15 companies to participate, helps provincial companies access the U.K. markets and facilitate new partnerships.

Read More: https://agoracom.com/ir/MaitriHealthTechnologies/forums/discussion/topics/759354-maitri-health-technologies-chosen-for-u-k-trade-mission/messages/2312670#message

Maitri Health Technologies $MTEC.ca Announces Chief Technology Officer $DOC.ca $DOCRF $WELL.ca $PRN.ca

Posted by AGORACOM-AB at 8:51 AM on Monday, April 12th, 2021
Maitri Health Technologies MTEC

VANCOUVER, BC , April 12, 2021 /PRNewswire/ – Maitri Health Technologies Corp. (” Maitri “) (CSE: MTEC) (FRA: D84), a global platform for healthcare supply security, today announced Andrew McCann, a digital innovator in cloud platforms and online user experiences, is joining as Chief Technology Officer (CTO).

Mr. McCann was a co-founder of DeviantArt, one of the first social media networks, and served as CTO until the company was acquired by Wix.com Ltd. (NASDAQ: WIX). During tenure as CTO, DeviantArt was a Hollywood -based online platform with over 40-million users and the world’s largest catalog of user created online images. At it’s peak, DeviantArt handled traffic of over two billion page views per month, requiring incredibly sophisticated data management and development.

Mr. McCann’s entrepreneurial innovations began earlier, when he co-founded Silicon Valley-based MediaScience Inc., acquired by Lycos, now part of Brightcom Group Ltd. (NSE: BCM), and built Sonique, one of the world’s first, and eventually second biggest, desktop audio players.

Mr. McCann has advised to health-tech companies, AI start-ups and does mentoring work with Creative Destruction Labs.

Read More: https://agoracom.com/ir/MaitriHealthTechnologies/forums/discussion/topics/758871-maitri-health-technologies-announces-chief-technology-officer/messages/2311574#message

Former Johnson & Johnson Executive Joins Advisory Board at Maitri Health Technologies $MTEC.ca $DOC.ca $DOCRF $WELL.ca $PRN.ca

Posted by AGORACOM-AB at 9:56 AM on Tuesday, March 23rd, 2021
Maitri Health Technologies MTEC
  • Bridget Ross brings extensive experience in MedTech development and services;
  • Joins advisory board of healthcare, logistics, capital markets and innovation leaders

VANCOUVER, BC , March 23, 2021 /PRNewswire/ – Maitri Health Technologies Corp. (” Maitri “) (CSE: MTEC) (FRA: D84), a global platform for healthcare supply security, today announced the appointment of Bridget Ross to its Advisory Board.

Ms. Ross is currently CEO of ChroniSense Medical, Ltd., an Israel -based MedTech company and maker of wearable, medical-grade disease management devices. Ms. Ross serves as a Board Director for LeMaitre Vascular Inc. (NASDAQ: LMAT) and as a mentor for early stage MedTech companies through MassMEDIC and the Canadian Consulate Technology Accelerator, in Boston , MA. 

For three decades, she held several executive roles at the world’s largest broadly based healthcare company, Johnson & Johnson (J&J).

“Bridget brings an unmatched level of experience and success to Maitri’s extended team,” said Andrew Morton, CEO of Maitri. “Maitri is uniquely positioned to modernize healthcare systems for governments, healthcare systems and businesses to function well beyond the pandemic. Bridget’s counsel and insights on product development will be invaluable as we continue to evolve and execute our integrated PPE and technology strategy.”

Read More: https://agoracom.com/ir/MaitriHealthTechnologies/forums/discussion/topics/757866-former-johnson-johnson-executive-joins-advisory-board-at-maitri-health-technologies/messages/2309370#message

VIDEO – Maitri Health Technologies $MTEC.ca Moves into High Gear, with Health Canada Approval of Domestically Manufactured #N95 Masks $DOC.ca $DOCRF $WELL.ca $PRN.ca

Posted by AGORACOM-JC at 8:45 PM on Thursday, March 18th, 2021
http://blog.agoracom.com/wp-content/uploads/2021/03/Maitri-MTEC-300-x-300.jpg

When COVID hit North America 12 months ago, there was no supply chain in place to handle the parabolic surge of demand for PPE (personal protective equipment – masks, shields, testing kits, etc.). 

An industry of “brokers” spawned overnight to fill the demand of buyers who were desperate and scrambling for product. In Canada, news reports highlighted how healthcare workers and businesses were shortchanged on international orders, or worse: shipped counterfeit or uncertified N95 masks that put people at greater risk of exposure and illness.

Enter Maitri: a global platform for healthcare supply security whose main focus provides a reliable source of certified PPE (personal protective equipment) and testing solutions through an onshore manufacturing model. 

  • The company has just been announced as one of the few manufacturers of domestically manufactured N95 masks to receive Health Canada certification
  • It’s a huge vote of confidence in the company and its products

Maitri’s model has led to the creation of innovative and industry leading products including 3D certified surgical masks and patent-pending face shields, all integrated with technology to help track, trace and enable safer workplaces and communities.

  • The global personal protective equipment market size is expected to reach USD $123.38bn by 2027,
  • That’s a CAGR of 9.6%.

Maitri CEO Andrew Morton talks us through the size of the market, the significance of the Health Canada certification, and the headline-grabbing $2m deal with Loop Insights:

Maitri Health Technologies $MTEC.ca Announces Health Canada Approval of Domestically Manufactured N95 Masks $DOC.ca $DOCRF $WELL.ca $PRN.ca

Posted by AGORACOM-AB at 10:13 AM on Wednesday, March 17th, 2021
Maitri Health Technologies MTEC
  • Medical-grade protective gear designed and made in Canada ;
  • Offers greater certainty regarding source, quality and timely delivery of genuine N95 masks.

VANCOUVER, BC , March 17, 2021 /CNW/ – Maitri Health Technologies Corp. (“Maitri”) (CSE: MTEC) (FRA: D84), a global platform for healthcare supply security, today announced the availability of N95 medical-grade protective masks, one of the few, domestically manufactured N95 masks to receive Health Canada certification.

Health Canada Approved N95 Mask Offered By Maitri Health Technologies. (CNW Group/Maitri Health Technologies Corp.)

N95 masks are among the most in-demand and difficult to source pieces of personal protective equipment (PPE) commonly used by hospital, healthcare and other frontline workers. N95 masks filter out at least 95 per cent of very small particles, including airborne droplets.

Maitri’s N95 masks, manufactured in Port Coquitlam, B.C. through an exclusive partnership with INNO Lifecare, were approved by Health Canada in March.

“Maitri is delivering what governments and organizations across Canada have sorely needed and requested since the beginning of the pandemic – a domestically manufactured and certified N95 mask,” said Andrew Morton, CEO of Maitri.

Read More: https://agoracom.com/ir/MaitriHealthTechnologies/forums/discussion/topics/757491-maitri-health-technologies-announces-health-canada-approval-of-domestically-manufactured-n95-masks/messages/2308523#message

Primo Nutraceuticals Inc. $PRMO.ca receives Medical Device Establishment License (MDEL) from Health Canada

Posted by AGORACOM-JC at 8:35 AM on Wednesday, September 16th, 2020
  • Announced it has been issued a Medical Device Establishment License (“MDEL”) from Health Canada
  • MDEL is a license issued to companies for the activities of manufacturing, importing and distributing (selling) of all four classes of medical devices for human use in Canada
  • These classes include; nitrile gloves, N95 surgical masks & KN95 masks, surgical gowns, respirators and testing kits to name a few

VANCOUVER, British Columbia, Sept. 16, 2020 — PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVD) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) (“Primo” or the “Company”) is pleased to announce it has been issued a Medical Device Establishment License (“MDEL”) from Health Canada.

The MDEL is a license issued to companies for the activities of manufacturing, importing and distributing (selling) of all four classes of medical devices for human use in Canada.

These classes include; nitrile gloves, N95 surgical masks & KN95 masks, surgical gowns, respirators and testing kits to name a few.

The MDEL license is issued by Health Canada’s Regulatory Operations and Enforcement Branch (ROEB) based on an attestation that the establishment meets all of HC’s MDEL regulatory requirements.

During an inspection by Health Canada, MDEL license holders must demonstrate to Health Canada that they meet the regulatory requirements attested to, having in place related medical devices that they intend to import and/or distribute (sell) in Canada.

Richard Cindric, CEO of Primo comments:

“Obtaining a Medical Device Establishment License is a milestone and a key step towards accessing the MDEL market share through the sale of already Health Canada approved commercialized devices. We have seen an increase in demand for PPE and medical devices since the COVID-19 pandemic surfaced. Receiving the MDEL license allows for more efficient, convenient and cost effective delivery of PPE and medical devices to Canadians including institutional markets and those managed by Federal and Provincial governments.”

Joel DeBellefeuille, Director of Primo comments: 

“The team has been working feverishly over the last few weeks focusing solely on delivering important catalysts. This one is definitely a major game-changer!”

About Primo Nutraceuticals Inc.

Primo Nutraceuticals Inc. (“Primo” or the “Company”) is dedicated to funding the rapid growth in production, processing, retail and branding of cannabis and non-cannabis natural health products in Canada and the United States. Primo has invested in several brands and is pursuing partnerships with retailers and distribution companies in Canada and the United States. Primo’s management is in the process of building a corporate road map to further vertically integrate the Company, specifically by way of the “Primo”  & “Thrive,” brands and a selection of curated partner brands. Most recently Primo announced that it has received its Natural Product Number (NPN) and it has been issued a Medical Device Establishment License (MDEL) from Health Canada.

On behalf of the Board of Directors

PRIMO NUTRACEUTICALS INC.

Andy Jagpal

Andy Jagpal
President and Director

For further information, please contact Zoltan, IR Representative at: 604-722-0305, or; [email protected].

To learn more about what this news means to the shareholders visit:

www.primonutraceuticals.com
www.twitter.com/Prmoinc
www.thrivecbd.com
www.mariannacorp.com
www.dcppe.net

FORWARD LOOKING STATEMENTS: This news release contains certain forward-looking statements within the meaning of Canadian securities laws. Forward-looking statements are based on the expectations and opinions of the Company’s management on the date the statements are made. The assumptions used in the preparation of such statements, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.No regulatory authority has approved or disapproved the information contained in this news release.